JADE SPRING
JADE SPRING, licence 80046612: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Eastern Currents Ltd.
- NPN or DIN-HM
- 80046612
- Status
- Inactive licence
- Licence date
- 27 November 2013
- Revision date
- 8 July 2014
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Trichosanthes kirilowii Maxim.: L'absence de trichosanthine doit être prouvée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trichosanthes kirilowii Source : Fruit Extraction ratio : 7.5:1.0 Dry plant equivalent : 225.0 mg | 30.0 mg | Not calculated |
| Codonopsis pilosula Source : Racine Extraction ratio : 7.5:1.0 Dry plant equivalent : 375.0 mg | 50.0 mg | Not calculated |
| Morus alba Source : Feuille Extraction ratio : 7.5:1.0 Dry plant equivalent : 187.5 mg | 25.0 mg | Not calculated |
| Anemarrhena asphodeloides Source : Rhizome Extraction ratio : 7.5:1.0 Dry plant equivalent : 225.0 mg | 30.0 mg | Not calculated |
Non-medicinal ingredients
Fécule de pomme de terre, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Comprimé | 3.0 Jour(s) |
Uses authorised in Canada
Product manufactured based on Traditional Chinese Medicine theory.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For health care practitioner dispensing only. Consult a health care practitioner for prolonged use; if symptoms persist or worsen, or if new symptoms develop; and prior to use if you have serious or major conditions or if taking prescription medications.
Source
Official Health Canada record, licence 80046612
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.